How Long Does Ketamine Relief Last?
“How long will it last?” is almost always one of the first questions patients ask after we explain that ketamine may produce antidepressant effects more quickly than many traditional medications.
It is a completely reasonable question. The honest answer is more nuanced than either enthusiastic press coverage or cautious disclaimers fully convey. Duration of benefit after ketamine treatment varies meaningfully across individuals, conditions, and treatment plans. Understanding that variability is essential to setting realistic expectations and building a maintenance strategy that works.
At Albany Ketamine Infusions, we make this conversation a central part of how we work with every patient.
What Research Can and Cannot Tell Us About Duration
Early studies of ketamine for depression often followed patients for a relatively short period after a single infusion. For many people who responded initially, symptoms returned within days or weeks. Those studies were important, but they were not designed to predict what happens after a personalized course of treatment, ongoing follow-up, or maintenance care.
Research on repeated infusions suggests that some patients experience a longer period of improvement after a series than after a single session. But duration varies widely. Some patients maintain benefits for weeks or months, while others notice symptoms returning sooner. We cannot predict in advance which timeline will apply to any one patient.
For patients beginning an IV ketamine infusion series, we focus on how they respond over time rather than promising a fixed duration of relief.
Why Duration Varies From Patient to Patient
Condition, history, and treatment goals all matter. Patients with treatment-resistant depression may have a different response pattern than patients seeking care for chronic pain conditions such as CRPS or neuropathic pain.
Different conditions involve different clinical considerations, and response curves can vary accordingly. That is why we do not apply a single maintenance schedule to every patient.
Some patients also include ketamine-assisted psychotherapy as part of a broader care plan. Research into how psychotherapy may affect longer-term outcomes is still evolving, but therapeutic preparation and integration can be meaningful components of treatment for the right patient.
Building an Individualized Maintenance Plan
At Albany Ketamine Infusions, we monitor response throughout and after an initial treatment series. We track how each patient is progressing over time and use that information to guide decisions about whether, and when, additional sessions may be appropriate.
Some patients prefer a watch-and-wait approach after their initial series. Others may choose to discuss a maintenance plan before symptoms return. We work with each patient to design a strategy that fits their clinical reality, goals, and preferences.
A question that often follows the duration question is: “Will ketamine stop working if I use it too often?”
This is a legitimate concern. The evidence on long-term and maintenance ketamine use is still developing, which is why we do not recommend ad hoc treatment scheduling. Any additional sessions should be considered as part of a structured, individualized plan with appropriate clinical oversight.
At-Home Ketamine and Duration of Relief
Our at-home ketamine program introduces its own treatment considerations. At-home care involves a different route of administration, setting, and schedule than in-office IV infusions.
At-home ketamine is an off-label treatment involving a controlled substance, and it requires full medical supervision. We manage dose, frequency, follow-up, and any adjustments with the same care we bring to in-office treatment.
The right schedule is not universal. Some patients may need more frequent support during an active phase of care, while others may transition to less frequent follow-up. We evaluate this based on response, safety considerations, and the full clinical picture.
Planning Around Uncertainty
One barrier patients face is the uncertainty itself. When someone is trying to plan their life around work schedules, family responsibilities, and financial considerations, it can be difficult not knowing exactly how long relief will last.
We address that uncertainty by building flexibility into the plan from the beginning. That may include an initial treatment series, reassessment at defined points, and a clear process for discussing whether additional care is appropriate.
This does not eliminate uncertainty, but it gives patients a structure for making informed decisions instead of relying on a one-size-fits-all timeline.
Cost and Long-Term Planning
The cost conversation includes more than an initial treatment series. It also includes the possibility of ongoing follow-up or maintenance care. Coverage and out-of-pocket costs vary, and we discuss practical considerations openly during the consultation process.
We want patients to understand what a realistic and sustainable plan may look like for their individual situation. Our role is not to push patients toward more treatment than they need. It is to help them make informed decisions about the option most likely to support their goals.
Supporting Long-Term Progress
Ketamine’s duration of benefit is not a fixed biological number. Individual response, treatment planning, follow-up care, support systems, and broader mental health routines can all be relevant.
Sleep, movement, stress management, and continued therapeutic engagement may be valuable parts of a larger care plan. They are not substitutes for clinical treatment, and they do not guarantee a specific duration of relief. But they can support the work patients are doing during and after treatment. For a deeper look at how ketamine interacts with the brain to produce these effects, see our overview of what ketamine infusion therapy does to your brain.
Frequently Asked Questions
For additional practical information, visit our Frequently Asked Questions.
Does ketamine work permanently for depression?
There is no single answer for every patient. Some people report benefits that last for months, while others need ongoing maintenance or additional support. We do not frame “permanent” relief as a realistic expectation for most patients. Instead, we focus on meaningful improvement and a sustainable plan based on each patient’s response.
How do I know when it is time for a booster infusion?
We help patients track their symptom trajectory and establish personal benchmarks for when to contact our team. Changes in mood, functioning, pain levels, sleep, or daily coping can all be relevant. The timing of additional treatment should be based on an individualized plan rather than a universal schedule.
Can lifestyle changes help ketamine relief last longer?
Healthy routines and continued psychotherapy can be valuable parts of overall mental health care. Regular exercise, sleep consistency, stress-management practices, and therapeutic engagement may support broader well-being, but they are not substitutes for ketamine treatment and cannot guarantee a specific duration of benefit.
Is there a maximum number of ketamine infusions I can have?
There is no universally established maximum that applies to every patient. The decision about additional treatment depends on your response, medical history, treatment goals, and ongoing clinical monitoring. We aim to use an individualized approach rather than treating ketamine as an open-ended protocol.
Do duration effects differ for pain versus depression?
They can. Pain conditions and mood conditions are evaluated independently, and response patterns can differ based on the individual condition, treatment approach, and patient history. We do not assume the same schedule will work for every diagnosis or every patient.
Key Takeaways
- A single ketamine infusion may provide short-term benefit for some patients, while a series of treatments may lead to a longer period of improvement for others.
- Duration varies significantly by individual response, condition, treatment history, and follow-up plan.
- Maintenance or booster sessions may be considered when clinically appropriate, but the timing should be individualized.
- At-home ketamine requires full medical supervision, careful follow-up, and individualized dose management.
- Results vary by individual. Discuss with your provider what a realistic and sustainable plan may look like for your situation.
Conclusion
Ketamine’s relief can be meaningful for many patients, but we do not pretend the answers are simple or promise a fixed timeline. What we do is take the time to build a plan with each patient that is grounded in evidence, honest about variability, and designed to support the most durable benefit possible.
If you are in the Albany area and want to understand how a ketamine program might fit into your life, we invite you to schedule a consultation with our team.
About Dr. Philip Hansen
Dr. Philip Hansen is a board-certified anesthesiologist who trained at Albany Medical Center. He established Albany Ketamine Infusions in partnership with Dr. Brooks, building on his training at NY Ketamine Infusions. Dr. Hansen graduated from the University of Kansas School of Medicine and holds membership in the American Society of Anesthesia, the American Medical Association, and the New York State Society of Anesthesiologists. He provides medical oversight for both in-office IV ketamine infusions and at-home telehealth ketamine programs for patients across New York, New Jersey, Florida, and Texas.
Works Cited
Drozdz, S. J., Goel, A., McGarr, M. W., Katz, J., Ritvo, P., Mattina, G. F., Bhat, V., Diep, C., & Ladha, K. S. (2022). Ketamine assisted psychotherapy: A systematic narrative review of the literature. Journal of Pain Research, 15, 1691–1706. DOI: 10.2147/JPR.S360733
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013). Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biological Psychiatry, 74(4), 250–256. DOI: 10.1016/j.biopsych.2012.06.022
Orhurhu, V., Orhurhu, M. S., Bhatia, A., & Cohen, S. P. (2019). Ketamine infusions for chronic pain: A systematic review and meta-analysis of randomized controlled trials. Anesthesia & Analgesia, 129(1), 241–254. DOI: 10.1213/ANE.0000000000004185
Phillips, J. L., Norris, S., Talbot, J., Birmingham, M., Hatchard, T., Ortiz, A., Owoeye, O., Batten, L. A., & Blier, P. (2019). Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial. American Journal of Psychiatry, 176(5), 401–409. DOI: 10.1176/appi.ajp.2018.18070834
Smith-Apeldoorn, S. Y., Veraart, J. K. E., Spijker, J., Kamphuis, J., & Schoevers, R. A. (2022). Maintenance ketamine treatment for depression: A systematic review of efficacy, safety, and tolerability. The Lancet Psychiatry, 9(11), 907–921. DOI: 10.1016/S2215-0366(22)00317-0
The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Results may vary. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether this treatment is appropriate for you.